MicroRNA-regulated proinflammatory cytokines in sarcopenia

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Fan, Jingjing ^a   Kou, Xianjuan ^a   Yang, Yi ^a   Chen, Ning ^a  

^a WUHAN SPORTS UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MICRORNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

AGING; CYTOKINE RELEASE; GENE EXPRESSION; GENETIC REGULATION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; NONHUMAN; REVIEW; SARCOPENIA; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; INTERLEUKIN-6; MICRORNAS; SARCOPENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84976600360     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/1438686     Document Type: Review

References (113)

1. J. E. Morley, S. D. Anker, and S. vonHaehling, "Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014, " Journal of Cachexia, Sarcopenia and Muscle, vol. 5, no. 4, pp. 253-259, 2014.
2. J. Fan, X. Kou, S. Jia, X. Yang, Y. Yang, and N. Chen, "Autophagy as a potential target for sarcopenia, " Journal of Cellular Physiology, vol. 231, no. 7, pp. 1450-1459, 2016.
3. S. C. Kandarian and R. W. Jackman, "Intracellular signaling during skeletal muscle atrophy, " Muscle and Nerve, vol. 33, no. 2, pp. 155-165, 2006.
4. J. R. White, A. L. Confides, S. Moore-Reed, J. M. Hoch, and E. E. Dupont-Versteegden, "Regrowth after skeletal muscle atrophy is impaired in aged rats, despite similar responses in signaling pathways, " Experimental Gerontology, vol. 64, pp. 17-32, 2015.
5. P. Kaasik, M. Umnova, A. Pehme et al., "Ageing and dexamethasone associated sarcopenia: peculiarities of regeneration, " Journal of Steroid Biochemistry and Molecular Biology, vol. 105, no. 1-5, pp. 85-90, 2007.
6. C. Howard, L. Ferrucci, K. Sun et al., "Oxidative protein damage is associated with poor grip strength among older women living in the community, " Journal of Applied Physiology, vol. 103, no. 1, pp. 17-20, 2007.
7. R. A. Miller, "The aging immune system: primer and prospectus, " Science, vol. 273, no. 5271, pp. 70-74, 1996.
8. E. K. Merritt, M. J. Stec, A. Thalacker-Mercer et al., "Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans, " Journal of Applied Physiology, vol. 115, no. 6, pp. 937-948, 2013.
9. J. S. W. Lee, T.-W. Auyeung, T. Kwok, E. M. C. Lau, P.-C. Leung, and J. Woo, "Associated factors and health impact of sarcopenia in older Chinese men and women: a cross-sectional study, " Gerontology, vol. 53, no. 6, pp. 404-410, 2008.
10. D. Cai, J. D. Frantz, N. E. Tawa Jr. et al., "IKKβ/NF-κB activation causes severe muscle wasting in mice, " Cell, vol. 119, no. 2, pp. 285-298, 2004.
11. A. S. Adler, S. Sinha, T. L. A. Kawahara, J. Y. Zhang, E. Segal, and H. Y. Chang, "Motif module map reveals enforcement of aging by continual NF-κB activity, " Genes & Development, vol. 21, no. 24, pp. 3244-3257, 2007.
12. S. L. Budui, A. P. Rossi, and M. Zamboni, "The pathogenetic bases of sarcopenia, " Clinical Cases in Mineral and Bone Metabolism, vol. 12, no. 1, pp. 22-26, 2015.
13. J. A. Batsis, T. A. Mackenzie, J. D. Jones, F. Lopez-Jimenez, and S. J. Bartels, "Sarcopenia, sarcopenic obesity and inflammation: results from the 1999-2004 National Health and Nutrition Examination Survey, " Clinical Nutrition, 2016.
14. T. N. Kim and K. M. Choi, "The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease, " Journal of Cellular Biochemistry, vol. 116, no. 7, pp. 1171-1178, 2015.
15. C. M. Phillips and I. J. Perry, "Does inflammation determine metabolic health status in obese and nonobese adults?" Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 10, pp. E1610-E1619, 2013.
16. D. R. Green, L. Galluzzi, and G. Kroemer, "Mitochondria and the autophagy-inflammation-cell death axis in organismal aging, " Science, vol. 333, no. 6046, pp. 1109-1112, 2011.
17. F. Ko, P. Abadir, R. Marx et al., "Impaired mitochondrial degradation by autophagy in the skeletal muscle of the aged female interleukin 10 null mouse, " Experimental Gerontology, vol. 73, pp. 23-27, 2016.
18. C. Correia-Melo, F. D. Marques, R. Anderson et al., "Mitochondria are required for pro-ageing features of the senescent phenotype, " The EMBO Journal, vol. 35, no. 7, pp. 724-742, 2016.
19. O. Kepp, L. Galluzzi, and G. Kroemer, "Mitochondrial control of the NLRP3 inflammasome, " Nature Immunology, vol. 12, no. 3, pp. 199-200, 2011.
20. K. Shimada, T. R. Crother, J. Karlin et al., "Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis, " Immunity, vol. 36, no. 3, pp. 401-414, 2012.
21. Q. Li and J. F. Engelhardt, "Interleukin-1β induction of NFκB is partially regulated by H2O2-mediated activation of NFκBinducing kinase, "The Journal of Biological Chemistry, vol. 281, no. 3, pp. 1495-1505, 2006.
22. C. Fan, Q. Li, Y. Zhang et al., "IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation, " The Journal of Clinical Investigation, vol. 113, no. 5, pp. 746-755, 2004.
23. S. Sriram, S. Subramanian, D. Sathiakumar et al., "Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated throughNF-κB, " Aging Cell, vol. 10, no. 6, pp. 931-948, 2011.
24. M. G. Rhoads, S. C. Kandarian, F. Pacelli, G. B. Doglietto, and M. Bossola, "Expression of NF-κB and IκB proteins in skeletal muscle of gastric cancer patients, " European Journal of Cancer, vol. 46, no. 1, pp. 191-197, 2010.
25. J. P. White, M. J. Puppa, S. Gao, S. Sato, S. L. Welle, and J. A. Carson, "Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK, " American Journal of Physiology-Endocrinology and Metabolism, vol. 304, no. 10, pp. E1042-E1052, 2013.
26. K. L. McIntire, Y. Chen, S. Sood, and R. Rabkin, "Acute uremia suppresses leucine-induced signal transduction in skeletalmuscle, " Kidney International, vol. 85, no. 2, pp. 374-382, 2014.
27. W. A. He, E. Berardi, V. M. Cardillo et al., "NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia, " The Journal of Clinical Investigation, vol. 123, no. 11, pp. 4821-4835, 2013.
28. B. Wang, G. Yang, X. Liang, M. Zhu, and M. Du, "Grape seed extract prevents skeletal muscle wasting in interleukin knockout mice, " BMC Complementary and Alternative Medicine, vol. 14, article 162, 2014.
29. J. M. Peake, P. Della Gatta, K. Suzuki, and D. C. Nieman, "Cytokine expression and secretion by skeletalmuscle cells: regulatory mechanisms and exercise effects, " Exercise Immunology Review, vol. 21, pp. 8-25, 2015.
30. M. Podbregar, M. Lainscak, O. Prelovsek, and T. Mars, "Cytokine response of cultured skeletal muscle cells stimulated with proinflammatory factors depends on differentiation stage, " TheScientificWorld Journal, vol. 2013, Article ID617170, 8 pages, 2013.
31. M. Molanouri Shamsi, Z. H. Hassan, R. Gharakhanlou et al., "Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training, " Endocrine, vol. 46, no. 1, pp. 60-69, 2014.
32. M. Visser, M. Pahor, D. R. Taaffe et al., "Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the Health ABC Study, " Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, vol. 57, no. 5, pp. M326-M332, 2002.
33. N. Giuliani, P. Sansoni, G. Girasole et al., "Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age-and menopause-related changes, " Experimental Gerontology, vol. 36, no. 3, pp. 547-557, 2001.
34. O. P. Kristiansen and T. Mandrup-Poulsen, "Interleukin-6 and diabetes: the good, the bad, or the indifferent?" Diabetes, vol. 54, supplement 2, pp. S114-S124, 2005.
35. D. Kamimura, K. Ishihara, and T. Hirano, "IL-6 signal transduction and its physiological roles: the signal orchestration model, " Reviews of Physiology, Biochemistry and Pharmacology, vol. 149, pp. 1-38, 2003.
36. W. B. Ershler and E. T. Keller, "Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty, " Annual Review of Medicine, vol. 51, pp. 245-270, 2000.
37. S. K. Watkins, Z. Zhu, E. Riboldi et al., "FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer, " The Journal of Clinical Investigation, vol. 121, no. 4, pp. 1361-1372, 2011.
38. M. T. Tierney, T. Aydogdu, D. Sala et al., "STAT3 signaling controls satellite cell expansion and skeletal muscle repair, " Nature Medicine, vol. 20, no. 10, pp. 1182-1186, 2014.
39. C. J. Green, K. Macrae, S. Fogarty, D. G. Hardie, K. Sakamoto, and H. S. Hundal, "Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor κB signalling in rat skeletal muscle cells by AMP-activated protein kinase, " Biochemical Journal, vol. 435, no. 2, pp. 463-474, 2011.
40. L. Zhang, V. Rajan, E. Lin et al., "Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease, " The FASEB Journal, vol. 25, no. 5, pp. 1653-1663, 2011.
41. A. L. Carey, G. R. Steinberg, S. L. Macaulay et al., "Interleukin-increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMPactivated protein kinase, " Diabetes, vol. 55, no. 10, pp. 2688-2697, 2006.
42. C. R. Bruce and D. J. Dyck, "Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-α, " American Journal of Physiology-Endocrinology and Metabolism, vol. 287, no. 4, pp. E616-E621, 2004.
43. S. Franckhauser, I. Elias, V. Rotter Sopasakis et al., "Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice, " Diabetologia, vol. 51, no. 7, pp. 1306-1316, 2008.
44. F. Haddad, F. Zaldivar, D. M. Cooper, and G. R. Adams, "IL-6-induced skeletal muscle atrophy, " Journal of Applied Physiology, vol. 98, no. 3, pp. 911-917, 2005.
45. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg, and M. Visser, "Inflammatory markers and loss of muscle mass (sarcopenia) and strength, " The American Journal of Medicine, vol. 119, no. 6, pp. 526. e9-526. e17, 2006.
46. C.-W. Yang, C.-I. Li, T.-C. Li et al., "Association of sarcopenic obesity with higher serum high-sensitivity c-reactive protein levels in Chinese older males-a community-based study (Taichung Community Health Study-Elderly, TCHS-E), " PLoS ONE, vol. 10, no. 7, article e0132908, 2015.
47. M. Girven, H. F. Dugdale, D. J. Owens, D. C. Hughes, C. E. Stewart, and A. P. Sharples, "L-glutamine improves skeletal muscle cell differentiation and preventsmyotube atrophy after cytokine (TNF-α) stress via reduced p38 MAPK signal transduction, " Journal of Cellular Physiology, 2016.
48. J. S. Otis, S. Niccoli, N. Hawdon et al., "Pro-inflammatory mediation of myoblast proliferation, " PLoS ONE, vol. 9, no. 3, Article ID e92363, 2014.
49. S. Ciciliot and S. Schiaffino, "Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications, " Current Pharmaceutical Design, vol. 16, no. 8, pp. 906-914, 2010.
50. G. Luo, D. D. Hershko, B. W. Robb, C. J. Wray, and P.-O. Hasselgren, "IL-1β stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-κB, " American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 284, no. 5, pp. R1249-R1254, 2003.
51. D.-T. Wang, Y. Yin, Y.-J. Yang et al., "Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes, " International Immunopharmacology, vol. 19, no. 2, pp. 206-213, 2014.
52. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg et al., "Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength, " Journals of Gerontology-Series A Biological Sciences and Medical Sciences, vol. 64, no. 11, pp. 1183-1189, 2009.
53. J. S. Greiwe, C. Bo, D. C. Rubin, K. E. Yarasheski, and C. F. Semenkovich, "Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans, " The FASEB Journal, vol. 15, no. 2, pp. 475-482, 2001.
54. N. Mangner, A. Linke, A. Oberbach et al., "Exercise training prevents TNF-α induced loss of force in the diaphragm of mice, " PLoS ONE, vol. 8, no. 1, Article ID e52274, 2013.
55. Q. Zhao, S. T. Yang, J. J. Wang et al., "TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway, " Biochemical and Biophysical Research Communications, vol. 458, no. 4, pp. 790-795, 2015.
56. D. Coletti, V. Moresi, S. Adamo, M. Molinaro, and D. Sassoon, "Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration, " Genesis, vol. 43, no. 3, pp. 120-128, 2005.
57. R. A. Frost and C. H. Lang, "Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass, " Journal of Applied Physiology, vol. 103, no. 1, pp. 378-387, 2007.
58. C. H. Lang, R. A. Frost, and T. C. Vary, "Regulation of muscle protein synthesis during sepsis and inflammation, " American Journal of Physiology-Endocrinology and Metabolism, vol. 293, no. 2, pp. E453-E459, 2007.
59. L. Di Renzo, F. Sarlo, L. Petramala et al., "Association between-308 G/A TNF-α polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome, " Disease Markers, vol. 35, no. 6, pp. 615-623, 2013.
60. B. Pijet, M. Pijet, A. Litwiniuk, M. Gajewska, B. Pajak, and A. Orzechowski, "TNF-α and IFN-s-dependent muscle decay is linked to NF-κB-and STAT-1α-stimulated Atrogin1 andMuRF1 genes inC2C12myotubes, "Mediators of Inflammation, vol. 2013, Article ID 171437, 18 pages, 2013.
61. L. S. Quinn, B. G. Anderson, L. Strait-Bodey, A. M. Stroud, and J. M. Argues, "Oversecretion of interleukin-15 fromskeletal muscle reduces adiposity, " American Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 1, pp. E191-E202, 2009.
62. P. Bostrom, J. Wu, M. P. Jedrychowski et al., "A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis, " Nature, vol. 481, no. 7382, pp. 463-468, 2012.
63. M. M. Seldin and G. W. Wong, "Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines, " Adipocyte, vol. 1, no. 4, pp. 200-202, 2014.
64. A. Steensberg, C. P. Fischer, C. Keller, K. Moller, and B. K. Pedersen, "IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans, " American Journal of Physiology-Endocrinology and Metabolism, vol. 285, no. 2, pp. E433-E437, 2003.
65. M. J. Drummond, K. L. Timmerman, M. M. Markofski et al., "Short-term bed rest increases TLR4 and IL-6 expression in skeletal muscle of older adults, " American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 305, no. 3, pp. R216-R223, 2013.
66. P. S. Eisele, R. Furrer, M. Beer, and C. Handschin, "The PGC-coactivators promote an anti-inflammatory environment in skeletal muscle in vivo, " Biochemical and Biophysical Research Communications, vol. 464, no. 3, pp. 692-697, 2015.
67. S. Sczelecki, A. Besse-Patin, A. Abboud et al., "Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation, " American Journal of Physiology-Endocrinology and Metabolism, vol. 306, no. 2, pp. E157-E167, 2014.
68. P. S. Eisele, S. Salatino, J. Sobek, M. O. Hottiger, and C. Handschin, "The peroxisome proliferator-activated receptor γ coactivator 1α/β (PGC-1) coactivators repress the transcriptional activity of NF-κB in skeletal muscle cells, " Journal of Biological Chemistry, vol. 288, no. 4, pp. 2246-2260, 2013.
69. T. Wenz, S. G. Rossi, R. L. Rotundo, B. M. Spiegelman, and C. T. Moraes, "Increasedmuscle PGC-1α expression protects from sarcopenia and metabolic disease during aging, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 48, pp. 20405-20410, 2009.
70. N. Bushati and S. M. Cohen, "MicroRNA functions, " Annual Review of Cell and Developmental Biology, vol. 23, pp. 175-205, 2007.
71. E. Zacharewicz, S. Lamon, and A. P. Russell, "MicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease, " Frontiers in Physiology, vol. 4, article 266, 2013.
72. H. Guo, N. T. Ingolia, J. S. Weissman, and D. P. Bartel, "Mammalian microRNAs predominantly act to decrease target mRNA levels, " Nature, vol. 466, no. 7308, pp. 835-840, 2010.
73. J. Han, Y. Lee, K.-H. Yeom et al., "Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex, " Cell, vol. 125, no. 5, pp. 887-901, 2006.
74. K. W. Diebel, D. J. Claypool, and L. F. van Dyk, "A conserved RNA polymerase III promoter required for gammaherpesvirus TMER transcription and microRNAprocessing, " Gene, vol. 544, no. 1, pp. 8-18, 2014.
75. J. Winter, S. Jung, S. Keller, R. I. Gregory, and S. Diederichs, "Many roads to maturity: MicroRNA biogenesis pathways and their regulation, " Nature Cell Biology, vol. 11, no. 3, pp. 228-234, 2009.
76. Y. Cui, T. Huang, and X. Zhang, "RNA editing of microRNA prevents RNA-induced silencing complex recognition of target mRNA, " Open Biology, vol. 5, no. 12, Article ID150126, 2015.
77. P. Brodersen and O. Voinnet, "Revisiting the principles of microRNA target recognition and mode of action, " Nature Reviews Molecular Cell Biology, vol. 10, no. 2, pp. 141-148, 2009.
78. Z. Hu and A. E. Bruno, "The influence of 3′UTRs onMicroRNA function inferred from human SNP data, " Comparative and Functional Genomics, vol. 2011, Article ID 910769, 9 pages, 2011.
79. Y. Kim, B. Kim, and V. N. Kim, "Re-evaluation of the roles of DROSHA, Exportin 5, and DICER in microRNA biogenesis, " Proceedings of the National Academy of Sciences, vol. 113, no. 13, pp. E1881-E1889, 2016.
80. J. Brennecke, A. Stark, R. B. Russell, and S. M. Cohen, "Principles of microRNA-target recognition, " PLoS Biology, vol. 3, no. 3, article e85, 2005.
81. M. Quattrocelli and M. Sampaolesi, "The mesmiRizing complexity of microRNAs for striated muscle tissue engineering, " Advanced Drug Delivery Reviews, vol. 88, pp. 37-52, 2015.
82. D. Baltimore, M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov, "MicroRNAs: new regulators of immune cell development and function, " Nature Immunology, vol. 9, no. 8, pp. 839-845, 2008.
83. E. van Rooij, N. Liu, and E. N. Olson, "MicroRNAs flex their muscles, " Trends in Genetics, vol. 24, no. 4, pp. 159-166, 2008.
84. E. M. Small, J. R. O'Rourke, V. Moresi et al., "Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 9, pp. 4218-4223, 2010.
85. T. E. Callis, Z. Deng, J.-F. Chen, and D.-Z. Wang, "Muscling through the microRNA world, " Experimental Biology and Medicine, vol. 233, no. 2, pp. 131-138, 2008.
86. E. vanRooij, D. Quiat, B. A. Johnson et al., "Afamily ofmicroRNAs encoded by myosin genes governs myosin expression and muscle performance, " Developmental Cell, vol. 17, no. 5, pp. 662-673, 2009.
87. J.-F. Chen, T. E. Callis, and D.-Z. Wang, "microRNAs and muscle disorders, " Journal of Cell Science, vol. 122, no. 1, pp. 13-20, 2009.
88. T. Nakasa, M. Ishikawa, M. Shi, H. Shibuya, N. Adachi, and M. Ochi, "Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model, " Journal of Cellular and Molecular Medicine, vol. 14, no. 10, pp. 2495-2505, 2010.
89. M. J. Drummond, J. J. McCarthy, C. S. Fry, K. A. Esser, and B. B. Rasmussen, "Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids, " American Journal of Physiology-Endocrinology and Metabolism, vol. 295, no. 6, pp. E1333-E1340, 2008.
90. J. Contreras and D. S. Rao, "MicroRNAs in inflammation and immune responses, " Leukemia, vol. 26, no. 3, pp. 404-413, 2012.
91. B. Schroen and S. Heymans, "Small but smartmicroRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing, " Cardiovascular Research, vol. 93, no. 4, pp. 605-613, 2012.
92. E. M. Mercken, E. Majounie, J. Ding et al., "Age-associated miRNA alterations in skeletal muscle from rhesus monkeys reversed by caloric restriction, " Aging, vol. 5, no. 9, pp. 692-703, 2013.
93. Q.-J. Li, J. Chau, P. J. R. Ebert et al., "miR-181a is an intrinsic modulator of T cell sensitivity and selection, " Cell, vol. 129, no. 1, pp. 147-161, 2007.
94. A. Soriano-Arroquia, L. House, L. Tregilgas, E. Canty-Laird, and K. Goljanek-Whysall, "The functional consequences of agerelated changes in microRNA expression in skeletal muscle, " Biogerontology, 2016.
95. W. Xie, Z. Li, M. Li, N. Xu, and Y. Zhang, "miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo, " Biochemical and Biophysical Research Communications, vol. 430, no. 2, pp. 647-652, 2013.
96. R. W. Georgantas, K. Streicher, S. A. Greenberg et al., "Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatorymyopathies, " Arthritis and Rheumatology, vol. 66, no. 4, pp. 1022-1033, 2014.
97. R. S. Yadava, E. P. Foff, Q. Yu et al., "TWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy, " Human Molecular Genetics, vol. 24, no. 7, pp. 2035-2048, 2015.
98. S. K. Panguluri, S. Bhatnagar, A. Kumar et al., "Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice, " PLoS ONE, vol. 5, no. 1, Article ID e8760, 2010.
99. S. Roush and F. J. Slack, "The let-7 family of microRNAs, " Trends in Cell Biology, vol. 18, no. 10, pp. 505-516, 2008.
100. M. J. Drummond, J. J. McCarthy, M. Sinha et al., "Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis, " PhysiologicalGenomics, vol. 43, no. 10, pp. 595-603, 2011.
101. L. Q. Jiang, N. Franck, B. Egan et al., "Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7, " American Journal of Physiology-Endocrinology and Metabolism, vol. 305, no. 11, pp. E1359-E1366, 2013.
102. J. H. Yu, L. Long, Z. X. Luo, L. M. Li, and J. R. You, "Antiinflammatory role of microRNA let-7c in LPS treated alveolar macrophages by targeting STAT3, " Asian Pacific Journal of Tropical Medicine, vol. 9, no. 1, pp. 72-75, 2016.
103. M. Jiang, Y. Xiang, D. Wang et al., "Dysregulated expression of miR-146a contributes to age-related dysfunction of macrophages, " Aging Cell, vol. 11, no. 1, pp. 29-40, 2012.
104. F. Olivieri, M. R. Rippo, F. Prattichizzo et al., "Toll like receptor signaling in 'inflammaging': microRNA as new players, " Immunity and Ageing, vol. 10, no. 1, article 111, 2013.
105. L. N. Schulte, A. J. Westermann, and J. Vogel, "Differential activation and functional specialization of miR-146 and miR-in innate immune sensing, " Nucleic Acids Research, vol. 41, no. 1, pp. 542-553, 2013.
106. I. Eisenberg, A. Eran, I. Nishino et al., "Distinctive patterns of microRNAexpression in primarymuscular disorders, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17016-17021, 2007.
107. H. Y. Seok, M. Tatsuguchi, T. E. Callis, A. He, W. T. Pu, and D.-Z. Wang, "miR-155 inhibits expression of the MEF2A protein to repress skeletalmuscle differentiation, " The Journal of Biological Chemistry, vol. 286, no. 41, pp. 35339-35346, 2011.
108. K. D. Taganov, M. P. Boldin, K.-J. Chang, and D. Baltimore, "NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12481-12486, 2006.
109. E. Tili, J.-J. Michaille, A. Cimino et al., "Modulation of miR-and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock, " Journal of Immunology, vol. 179, no. 8, pp. 5082-5089, 2007.
110. A. P. Russell, S. Wada, L. Vergani et al., "Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis, " Neurobiology of Disease, vol. 49, no. 1, pp. 107-117, 2013.
111. W. Aoi, Y. Naito, K. Mizushima et al., "The microRNA miR-696 regulates PGC-1α inmouse skeletal muscle in response to physical activity, " American Journal of Physiology-Endocrinology and Metabolism, vol. 298, no. 4, pp. E799-E806, 2010.
112. G. L. Jensen, "Inflammation: roles in aging and sarcopenia, " Journal of Parenteral and Enteral Nutrition, vol. 32, no. 6, pp. 656-659, 2008.
113. A. M. Villani, M. Crotty, I. D. Cameron et al., "Appendicular skeletal muscle in hospitalised hip-fracture patients: development and cross-validation of anthropometric prediction equations against dual-energy X-ray absorptiometry, " Age and Ageing, vol. 43, no. 6, pp. 857-862, 2014.